Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.7M Buy
150,627
+11,300
+8% +$2.05M 1.06% 38
2026
Q1
$26.4M Buy
139,327
+21,100
+18% +$4.49M 0.88% 44
2025
Q4
$27.1M Sell
118,227
-191,112
-62% -$42M 0.87% 46
2025
Q3
$61.3M Hold
309,339
1.82% 17
2025
Q2
$61.1M Hold
309,339
2.09% 20
2025
Q1
$63.4M Buy
+309,339
New +$67.5M 2.23% 16
2023
Q4
Sell
-87,082
Closed -$19.2M 78
2023
Q3
$19.2M Buy
87,082
+24,591
+39% +$5.48M 0.61% 55
2023
Q2
$13.3M Buy
+62,491
New +$13.2M 0.43% 64

Other funds holding DHR

Braidwell's DHR Position: Q2 2026 in Review

Braidwell increased its Danaher (DHR) stake by 8.1% in Q2 2026, buying an estimated $2.05M and bringing the position to 150,627 shares worth $28.7M. The position accounts for 1.06% of the portfolio, ranked #38.

Braidwell first reported a position in DHR in Q2 2023 and has held it in 8 quarters since. The position peaked at $63.4M in Q1 2025. 2,092 funds tracked by Wall St. Rank hold DHR as of Q2 2026.

  • Braidwell held 150,627 shares of Danaher worth $28.7M as of Q2 2026.
  • Braidwell bought 11,300 Danaher shares in Q2 2026, an estimated $2.05M.
  • Danaher made up 1.06% of Braidwell's portfolio in Q2 2026, its #38 holding.
  • Braidwell first reported a position in Danaher in Q2 2023 and has held it in 8 quarters since.
  • Braidwell's Danaher position peaked at $63.4M in Q1 2025.
  • 2,092 funds tracked by Wall St. Rank held Danaher as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.